AbilityPharma receives WHO approval for its ABTL0812 anticancer drug to be named IBRILATAZAR

by AbilityPharma

AbilityPharma announces that the World Health Organization (WHO) has recommended ABTL0812, a first-in-class oral drug for cancer treatment that causes selective death of cancer cells through autophagy...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Heat Exposure During Pregnancy and Infan...

by ISGlobal - Instituto de Salud Global de Barcelona

New study finds an association between higher temperatures early in li...

Photos Stream